ArticleCancer immunology research2014

JAK2 expression is associated with tumor-infiltrating lymphocytes and improved breast cancer outcomes: implications for evaluating JAK2 inhibitors.

Chris P Miller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.